Inhibrx Inc (INBX)
34.46
-0.15
(-0.43%)
USD |
NASDAQ |
Apr 18, 16:00
34.50
+0.04
(+0.10%)
After-Hours: 20:00
Inhibrx Market Cap: 1.633B for April 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 1.633B |
| April 17, 2024 | 1.640B |
| April 16, 2024 | 1.640B |
| April 15, 2024 | 1.646B |
| April 12, 2024 | 1.658B |
| April 11, 2024 | 1.660B |
| April 10, 2024 | 1.657B |
| April 09, 2024 | 1.655B |
| April 08, 2024 | 1.645B |
| April 05, 2024 | 1.657B |
| April 04, 2024 | 1.642B |
| April 03, 2024 | 1.663B |
| April 02, 2024 | 1.652B |
| April 01, 2024 | 1.653B |
| March 28, 2024 | 1.657B |
| March 27, 2024 | 1.666B |
| March 26, 2024 | 1.662B |
| March 25, 2024 | 1.656B |
| March 22, 2024 | 1.654B |
| March 21, 2024 | 1.657B |
| March 20, 2024 | 1.659B |
| March 19, 2024 | 1.658B |
| March 18, 2024 | 1.656B |
| March 15, 2024 | 1.659B |
| March 14, 2024 | 1.658B |
| Date | Value |
|---|---|
| March 13, 2024 | 1.675B |
| March 12, 2024 | 1.670B |
| March 11, 2024 | 1.666B |
| March 08, 2024 | 1.684B |
| March 07, 2024 | 1.695B |
| March 06, 2024 | 1.692B |
| March 05, 2024 | 1.686B |
| March 04, 2024 | 1.689B |
| March 01, 2024 | 1.727B |
| February 29, 2024 | 1.736B |
| February 28, 2024 | 1.754B |
| February 27, 2024 | 1.875B |
| February 26, 2024 | 1.834B |
| February 23, 2024 | 1.814B |
| February 22, 2024 | 1.817B |
| February 21, 2024 | 1.814B |
| February 20, 2024 | 1.803B |
| February 16, 2024 | 1.785B |
| February 15, 2024 | 1.800B |
| February 14, 2024 | 1.780B |
| February 13, 2024 | 1.765B |
| February 12, 2024 | 1.794B |
| February 09, 2024 | 1.772B |
| February 08, 2024 | 1.765B |
| February 07, 2024 | 1.789B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
332.60M
Minimum
Jun 14 2022
1.886B
Maximum
Dec 17 2020
1.052B
Average
1.011B
Median
Market Cap Benchmarks
| Johnson & Johnson | 351.20B |
| Gilead Sciences Inc | 82.42B |
| Outlook Therapeutics Inc | 178.93M |
| Axonics Inc | 3.420B |
| NovaBay Pharmaceuticals Inc | 2.528M |
Market Cap Related Metrics
| PS Ratio | 902.08 |
| PEG Ratio | -0.1624 |
| Price to Book Value | 37.54 |
| Price | 34.46 |
| Earnings Yield | -14.86% |
| PEGY Ratio | -0.1624 |